JP2016510332A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016510332A5 JP2016510332A5 JP2015555373A JP2015555373A JP2016510332A5 JP 2016510332 A5 JP2016510332 A5 JP 2016510332A5 JP 2015555373 A JP2015555373 A JP 2015555373A JP 2015555373 A JP2015555373 A JP 2015555373A JP 2016510332 A5 JP2016510332 A5 JP 2016510332A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- content
- pharmaceutical composition
- arginine
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 claims 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims 5
- 240000004980 Rheum officinale Species 0.000 claims 5
- 235000008081 Rheum officinale Nutrition 0.000 claims 5
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 claims 5
- 229960002703 undecylenic acid Drugs 0.000 claims 5
- 229930064664 L-arginine Natural products 0.000 claims 4
- 235000014852 L-arginine Nutrition 0.000 claims 4
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 238000001816 cooling Methods 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 208000017520 skin disease Diseases 0.000 claims 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical group CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims 1
- 201000004624 Dermatitis Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 241000219061 Rheum Species 0.000 claims 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims 1
- 206010072170 Skin wound Diseases 0.000 claims 1
- 206010041899 Stab wound Diseases 0.000 claims 1
- 206010052428 Wound Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 238000005299 abrasion Methods 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 244000053095 fungal pathogen Species 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 229940041616 menthol Drugs 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 244000000010 microbial pathogen Species 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 206010040872 skin infection Diseases 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 244000052613 viral pathogen Species 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 238000010792 warming Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361757058P | 2013-01-25 | 2013-01-25 | |
| US61/757,058 | 2013-01-25 | ||
| PCT/US2014/013120 WO2014117056A1 (en) | 2013-01-25 | 2014-01-27 | Therapeutic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016510332A JP2016510332A (ja) | 2016-04-07 |
| JP2016510332A5 true JP2016510332A5 (https=) | 2016-06-23 |
| JP6408489B2 JP6408489B2 (ja) | 2018-10-17 |
Family
ID=51228097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015555373A Expired - Fee Related JP6408489B2 (ja) | 2013-01-25 | 2014-01-27 | 治療配合物（ｃｏｍｐｏｕｎｄｓ） |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10195242B2 (https=) |
| EP (1) | EP2948129B1 (https=) |
| JP (1) | JP6408489B2 (https=) |
| AU (1) | AU2014209162B2 (https=) |
| CA (1) | CA2894240C (https=) |
| DK (1) | DK2948129T3 (https=) |
| ES (1) | ES2659066T3 (https=) |
| NO (1) | NO2982810T3 (https=) |
| PL (1) | PL2948129T3 (https=) |
| PT (1) | PT2948129T (https=) |
| WO (1) | WO2014117056A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106729575A (zh) * | 2017-01-25 | 2017-05-31 | 深圳市艾梵诗生物技术有限公司 | 具有青少年抗菌消炎、祛痘淡印功效的中药组合物、美容产品及其制备方法 |
| EP3579855A4 (en) * | 2017-02-13 | 2020-12-16 | Wintermute Biomedical, Inc. | ANTI-PATHOGENIC THERAPEUTIC COMPOSITIONS |
| JP7608342B2 (ja) * | 2018-10-01 | 2025-01-06 | ウィンターミュート バイオメディカル，インク． | 治療用組成物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4150052A (en) | 1971-02-04 | 1979-04-17 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
| US5766614A (en) * | 1997-03-20 | 1998-06-16 | Yong; Liu | Burn treatment compositions containing herbal mix |
| JPH11269034A (ja) * | 1998-03-20 | 1999-10-05 | Shiseido Co Ltd | ニキビ改善用皮膚外用剤 |
| JP2000281528A (ja) * | 1999-03-31 | 2000-10-10 | Ichimaru Pharcos Co Ltd | 化粧料組成物 |
| US6841174B2 (en) * | 2000-09-20 | 2005-01-11 | Zeyad Technologies Llc | Herbal compositions and treatment methods |
| JP2002114670A (ja) | 2000-10-02 | 2002-04-16 | Noevir Co Ltd | 抗菌性皮膚外用剤 |
| US7288265B1 (en) * | 2000-10-16 | 2007-10-30 | Lectec Corporation | Treating viral infection at smallpox vaccination site |
| GB0221697D0 (en) | 2002-09-18 | 2002-10-30 | Unilever Plc | Novel compouds and their uses |
| US20060134095A1 (en) * | 2003-01-27 | 2006-06-22 | Shinobu Ito | Antioxidative composition and composition for external use |
| PL1685093T6 (pl) | 2003-11-21 | 2012-10-31 | Givaudan Sa | N-podstawiony p-mentanokarboksamid i zastosowanie N-podstawionych p-mentanokarboksamidów |
| US20120328544A1 (en) * | 2003-12-22 | 2012-12-27 | Nevada Naturals, Inc. | Dermatological Treatment Methods And Formulations |
| US9987217B2 (en) | 2004-06-18 | 2018-06-05 | Symrise Ag | Blackberry extract |
| CA2584528A1 (en) | 2004-09-17 | 2006-03-23 | Oystershell Nv | Composition for inhibiting or preventing the formation of a biofilm |
| GB0423652D0 (en) * | 2004-10-25 | 2004-11-24 | Univ Coventry | Kit |
| AU2006298442A1 (en) * | 2005-05-09 | 2007-04-12 | Foamix Ltd. | Saccharide foamable compositions |
| CN1969984B (zh) * | 2006-12-07 | 2010-12-29 | 刘爱芹 | 一种治疗皮肤粉刺和过敏的外用药 |
| AR065640A1 (es) * | 2007-03-09 | 2009-06-17 | Otsuka Pharma Co Ltd | Preparado liofilizado que contiene una vacuna contra la influenza y metodo para producir la misma |
| US8623335B2 (en) | 2007-09-10 | 2014-01-07 | Tauna Ann Waddington | Scar and rosacea and other skin care treatment composition and method |
| CN101991726A (zh) * | 2009-08-25 | 2011-03-30 | 肖华 | 一种治疗巨细胞病毒的药物组合物及其制备方法 |
| CN103533947A (zh) * | 2010-12-28 | 2014-01-22 | 卡梅迪斯有限公司 | 用于治疗和预防感染的植物提取物 |
| CN102178842B (zh) | 2011-04-27 | 2013-10-16 | 李梅华 | 一种治疗结核病的药物组合物及应用 |
| ES2966909T3 (es) | 2014-08-13 | 2024-04-25 | Akeso Biomedical Inc | Compuestos y composiciones antimicrobianos, y usos de los mismos |
-
2014
- 2014-01-27 PT PT147427462T patent/PT2948129T/pt unknown
- 2014-01-27 CA CA2894240A patent/CA2894240C/en not_active Expired - Fee Related
- 2014-01-27 EP EP14742746.2A patent/EP2948129B1/en not_active Not-in-force
- 2014-01-27 AU AU2014209162A patent/AU2014209162B2/en not_active Ceased
- 2014-01-27 JP JP2015555373A patent/JP6408489B2/ja not_active Expired - Fee Related
- 2014-01-27 WO PCT/US2014/013120 patent/WO2014117056A1/en not_active Ceased
- 2014-01-27 PL PL14742746T patent/PL2948129T3/pl unknown
- 2014-01-27 DK DK14742746.2T patent/DK2948129T3/da active
- 2014-01-27 ES ES14742746.2T patent/ES2659066T3/es active Active
- 2014-01-27 US US14/760,778 patent/US10195242B2/en active Active
-
2015
- 2015-07-24 NO NO15002198A patent/NO2982810T3/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201490647A1 (ru) | Производные бензотиазол-6-илуксусной кислоты и их применение для лечения вич-инфекции | |
| MX393855B (es) | Terapia de combinación que comprende un inhibidor de raf y trametinib | |
| EA201592250A1 (ru) | Пиразолопирролидиновые производные и их применение в лечение заболеваний | |
| EA201590371A1 (ru) | 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний | |
| EA201592256A1 (ru) | Производные имидазопирролидинона и их применение при лечении заболеваний | |
| IN2015DN00376A (https=) | ||
| BR112014009910A2 (pt) | formulações de sal de meglumina de ácido 1-(5,6-dicloro-1h-benzo[d]imidazol-2-il)-1h-pirazol-4-carboxílico | |
| HRP20161379T1 (hr) | Inhibitori hepatitis c virusa | |
| IN2014MN01755A (https=) | ||
| EA201490228A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
| EA201491889A1 (ru) | Соединения и способы для противовирусной терапии | |
| BR112013029246A2 (pt) | 4-amino-5-flúor-3-[6- (4-metilpiperazin- 1 - il) - 1h - benzimidazol - 2 - il] - 1h - quinolin-2-ona para uso no tratamento de carcinoma adenoide cístico | |
| BR112015007366A2 (pt) | derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças | |
| EA201491479A1 (ru) | Производные лупановых тритерпеноидов и их фармацевтическое применение | |
| BR112013019256A2 (pt) | inibição de il-17 e ifn-gama para o tratamento de inflamação autoimune | |
| PE20150161A1 (es) | Uso de laquinimod de dosis alta para el tratamiento de esclerosis multiple | |
| NZ720328A (en) | Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease | |
| EA033054B1 (ru) | Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения | |
| AR090592A1 (es) | Sales de 5-[(1r)-2-({2-[4-(2,2-difluoro-2-feniletoxi)fenil]etil}amino)-1-hidroxietil]-8-hidroxiquinolin-2(1h)-ona | |
| WO2013142182A3 (en) | Combination therapy of a mek inhibitor and igf1r inhibitor | |
| BR112015016184A2 (pt) | derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral | |
| RU2016112257A (ru) | Композиция для лечения гипертензии и/или фиброза | |
| JP2016538288A5 (https=) | ||
| JP2016510332A5 (https=) | ||
| CN109563051A (zh) | 作为pde4抑制剂的并环类化合物 |